Project description
European infrastructure for radionuclide production
Nuclear medicine uses radioactive molecules, so-called radiopharmaceuticals, and their radiation to provide diagnostic information and treat various medical conditions such as cancer. The radioactive elements, known as radionuclides, possess excess energy that is released by different types of radioactive decay. The key objective of the EU-funded PRISMAP project is to establish a European infrastructure and a common entry point for researchers and physicians in the field. The consortium will set up a sustainable source of highly pure non-conventional radionuclides for developments in medicine as well as protocols and services for the pharmaceutical industry and the healthcare sector, in a sustainable European medical radionuclide programme.
Objective
PRISMAP - The European medical isotope programme: Production of high purity isotopes by mass separation proposes to federate a consortium of the key European intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical research institutes and hospitals active in the translation of the emerging radionuclides into medical diagnosis and treatment. PRISMAP will create a single-entry point for a fragmented user community distributed amongst universities, research centres, industry and hospitals, in a similar way as the National Isotope Development Center NIDC supported by the Department of Energy (DOE) has provided radionuclide sources for users in the USA. PRISMAP brings together a consortium of 23 beneficiaries from 13 countries, one European Research Laboratory and an International Organisation. It further receives support of leading associations and institutions in the field such as the European Association of Nuclear Medicine (EANM) and the International Atomic Energy Agency (IAEA). Our main goal is to provide a sustainable source of high purity grade new radionuclides for medicine, involving from the onset upcoming major European infrastructures, to provide a single-entry point for all researchers active in this field including SMEs, global pharma, nuclear centres, hospitals and universities, using standardised access procedures. The new isotope enrichment and standardisation techniques triggered in PRISMAP will expand our services and provide them to yet unreachable remote European laboratories. PRISMAP thus strives to create a paradigm shift in the early phase research on radiopharmaceuticals, targeted drugs for cancer – one of the major diseases in Europe - theranostics and personalised medicine, shaping the European isotope landmark as a gold standard to accelerate the development of the pharma industry and ultimately of a better healthcare for the improvement of our citizens’ life.
Fields of science
- natural sciencesphysical sciencestheoretical physicsparticle physicsparticle accelerator
- medical and health sciencesclinical medicineradiologynuclear medicine
- medical and health sciencesclinical medicineoncology
- medical and health scienceshealth sciencespersonalized medicine
- natural scienceschemical sciencesnuclear chemistryradiation chemistry
Keywords
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
1211 Meyrin
Switzerland
See on map
Participants (22)
TW11 0LW Middlesex
See on map
5232 Villigen Psi
See on map
75015 PARIS 15
See on map
1000-043 Lisboa
See on map
2800 Kongens Lyngby
See on map
1011 Lausanne
See on map
14076 Caen
See on map
1160 Bruxelles / Brussel
See on map
44817 Saint Herblain
See on map
224 84 Lund
See on map
81675 Muenchen
See on map
3000 Leuven
See on map
2700 Wiener Neustadt
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1025 Saint Sulpice
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
6020 Innsbruck
See on map
38000 Grenoble
See on map
1049 Bruxelles / Brussel
See on map
05 400 Otwock
See on map
64291 Darmstadt
See on map
1586 RIGA
See on map
00044 Frascati
See on map
0313 Oslo
See on map